IL6ST and myeloid sarcoma: It may also point to as yet undisclosed effects of genomic cis-variants affecting cell-specific sgp130 isoform splicing or stability, and/or posttranslational processing and trafficking of sgp130, that are correlated to the main MS risk SNP.